enVVeno Medical Corporation (FRA:5HJ0)
Germany flag Germany · Delayed Price · Currency is EUR
10.50
0.00 (0.00%)
At close: Jan 16, 2026

enVVeno Medical Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
1.541.753.624.5654.739.33
Short-Term Investments
29.4141.442.7934.49--
Cash & Short-Term Investments
30.9543.1546.4139.0454.739.33
Cash Growth
-36.02%-7.02%18.87%-28.66%486.29%614.07%
Prepaid Expenses
0.550.580.510.390.310.23
Total Current Assets
31.543.7346.9239.4455.049.57
Property, Plant & Equipment
0.821.191.682.192.610.94
Other Long-Term Assets
0.030.030.030.030.050.03
Total Assets
32.3544.9548.6441.6657.710.54
Accounts Payable
0.631.010.430.650.561.39
Accrued Expenses
1.490.730.610.570.730.98
Short-Term Debt
-----0.31
Current Portion of Leases
0.290.360.340.310.290.31
Other Current Liabilities
-----0.19
Total Current Liabilities
2.42.11.371.531.583.19
Long-Term Leases
0.510.71.061.41.720.25
Total Liabilities
2.912.82.442.933.33.44
Common Stock
-----0
Additional Paid-In Capital
197.04194.01176.24145.25136.2672.42
Retained Earnings
-167.59-151.86-130.04-106.52-81.85-65.32
Total Common Equity
29.4542.1646.238.7354.47.1
Shareholders' Equity
29.4542.1646.238.7354.47.1
Total Liabilities & Equity
32.3544.9548.6441.6657.710.54
Total Debt
0.791.061.41.722.010.88
Net Cash (Debt)
30.1642.0945.0137.3352.728.45
Net Cash Growth
-36.14%-6.49%20.58%-29.20%523.64%1776.16%
Net Cash Per Share
51.9885.94128.07137.93212.59229.11
Filing Date Shares Outstanding
0.580.50.380.270.270.24
Total Common Shares Outstanding
0.580.50.380.270.270.07
Working Capital
29.141.6445.5537.9153.466.38
Book Value Per Share
50.9884.15121.42143.11201.0797.75
Tangible Book Value
29.4542.1646.238.7354.47.1
Tangible Book Value Per Share
50.9884.15121.42143.11201.0797.75
Machinery
-1.441.41.370.810.48
Leasehold Improvements
----0.190.16
Source: S&P Global Market Intelligence. Standard template. Financial Sources.